{
  "trial_id": "NCT01278212",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, stage of breast cancer, histological type of tumor, surgical treatment type, margin status, tumor focality, axillary staging status, adjuvant therapy type, hormone receptor status, HER2 receptor status, history of non-breast malignancies, residence location, financial/transportation hardship status, history and physical exam status, bilateral mammogram status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "stage",
          "stage of breast cancer"
        ],
        [
          "Tumor Subtypes",
          "histological type of tumor"
        ],
        [
          "Region of Enrollment",
          "residence location"
        ],
        [
          "Estrogen receptor status",
          "hormone receptor status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "tumor grade"
      ],
      "remaining_candidate_features": [
        "surgical treatment type",
        "margin status",
        "tumor focality",
        "axillary staging status",
        "adjuvant therapy type",
        "HER2 receptor status",
        "history of non-breast malignancies",
        "financial/transportation hardship status",
        "history and physical exam status",
        "bilateral mammogram status"
      ]
    },
    "processed-gen-response": "Age, gender, stage of breast cancer, histological type of tumor, surgical treatment type, margin status, tumor focality, axillary staging status, adjuvant therapy type, hormone receptor status, HER2 receptor status, history of non-breast malignancies, residence location, financial/transportation hardship status, history and physical exam status, bilateral mammogram status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Race/Ethnicity, Customized, Region of Enrollment, Tumor Stage, Histological Type, Surgical Margins Status, Axillary Staging, Hormone Receptor Status, HER2 Receptor Status, History of Non-breast Malignancies, Socioeconomic Status, Distance from Radiation Facility,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "stage",
          "Tumor Stage"
        ],
        [
          "tumor grade",
          "Histological Type"
        ],
        [
          "Estrogen receptor status",
          "Hormone Receptor Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Tumor Subtypes"
      ],
      "remaining_candidate_features": [
        "Surgical Margins Status",
        "Axillary Staging",
        "HER2 Receptor Status",
        "History of Non-breast Malignancies",
        "Socioeconomic Status",
        "Distance from Radiation Facility"
      ]
    },
    "processed-gen-response": "Age, Race/Ethnicity, Region of Enrollment, Tumor Stage, Histological Type, Surgical Margins Status, Axillary Staging, Hormone Receptor Status, HER2 Receptor Status, History of Non-breast Malignancies, Socioeconomic Status, Distance from Radiation Facility"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, BMI, Menopausal Status, Family History of Breast Cancer, History of Non-Breast Malignancies, ER Status, PR Status, HER2 Status, Tumor Size, Nodal Status, Surgical Margins, Adjuvant Chemotherapy, Adjuvant Hormone Therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Estrogen receptor status",
          "ER Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Tumor Subtypes",
        "tumor grade",
        "stage"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "BMI",
        "Menopausal Status",
        "Family History of Breast Cancer",
        "History of Non-Breast Malignancies",
        "PR Status",
        "HER2 Status",
        "Tumor Size",
        "Nodal Status",
        "Surgical Margins",
        "Adjuvant Chemotherapy",
        "Adjuvant Hormone Therapy."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, BMI, Menopausal Status, Family History of Breast Cancer, History of Non-Breast Malignancies, ER Status, PR Status, HER2 Status, Tumor Size, Nodal Status, Surgical Margins, Adjuvant Chemotherapy, Adjuvant Hormone Therapy."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, ethnicity, marital status, education level, occupation, income, residence location (Appalachian/rural vs. urban), distance from radiation facility, breast cancer stage, tumor size, tumor type (ductal carcinoma in situ or invasive adenocarcinoma), hormone receptor status (ER/PR), HER2 receptor status, axillary node status, surgical margins, history of non-breast malignancies, history of breast cancer, family history of breast cancer.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Region of Enrollment",
          "residence location (Appalachian/rural vs. urban)"
        ],
        [
          "stage",
          "breast cancer stage"
        ],
        [
          "Tumor Subtypes",
          "tumor type (ductal carcinoma in situ or invasive adenocarcinoma)"
        ],
        [
          "Estrogen receptor status",
          "hormone receptor status (ER/PR)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "tumor grade"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "marital status",
        "education level",
        "occupation",
        "income",
        "distance from radiation facility",
        "tumor size",
        "HER2 receptor status",
        "axillary node status",
        "surgical margins",
        "history of non-breast malignancies",
        "history of breast cancer",
        "family history of breast cancer"
      ]
    },
    "processed-gen-response": "age, sex, race, ethnicity, marital status, education level, occupation, income, residence location (Appalachian/rural vs. urban), distance from radiation facility, breast cancer stage, tumor size, tumor type (ductal carcinoma in situ or invasive adenocarcinoma), hormone receptor status (ER/PR), HER2 receptor status, axillary node status, surgical margins, history of non-breast malignancies, history of breast cancer, family history of breast cancer."
  }
}